RANKL and OPG Polymorphisms Are Associated with Aromatase Inhibitor-Related Musculoskeletal Adverse Events in Chinese Han Breast Cancer Patients

BACKGROUND: Breast cancer patients treated with aromatase inhibitors (AIs) may experience musculoskeletal adverse events (MS-AEs). Several studies have confirmed that the RANKL/RANK/OPG signaling pathway plays a dominant role in bone health. Therefore, this study aimed to analyze the relationship be...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:PLoS One
Main Authors: Wang, Jingxuan, Lu, Kangping, Song, Ying, Zhao, Shu, Ma, Wenjie, Xuan, Qijia, Tang, Dabei, Zhao, Hong, Liu, Lei, Zhang, Qingyuan
Format: Artigo
Sprog:Inglês
Udgivet: Public Library of Science 2015
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4547828/
https://ncbi.nlm.nih.gov/pubmed/26218592
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0133964
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker